These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 19583930)

  • 1. [Effects of Songling Xuemaikang Capsule on ambulatory blood pressure in treatment of essential hypertension: a single-blind randomized controlled trial].
    Fu L; Mao ZX; Wang J; Zhang J; Zheng TR; Wang SL
    Zhong Xi Yi Jie He Xue Bao; 2009 Jun; 7(6):509-13. PubMed ID: 19583930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Blood pressure lowering efficacy of telmisartan and amlodipine taking on the morning or at bedtime: ABPM results].
    Peng GC; Wang YF; Xiao Y; Chen JF; Yang Y; Ye YL; Sai SQ; Huang JX
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Jun; 41(6):484-7. PubMed ID: 24113040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of Songling Xuemaikang capsule for essential hypertension: A systematic review and meta-analysis of randomized controlled trials.
    Meng T; Wang P; Xie X; Li T; Kong L; Xu Y; Cao K; Gao Y; He Q; Lai X
    Phytomedicine; 2022 Dec; 107():154459. PubMed ID: 36183476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Songling Xuemaikang Capsule () for primary hypertension: A systematic review of randomized controlled trials.
    Yang XC; Xiong XJ; Yang GY; Wang HR; Wang J
    Chin J Integr Med; 2015 Apr; 21(4):312-20. PubMed ID: 24584755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Songling Xuemaikang capsules for patients with low-to-medium risk hypertension: study protocol for a randomized controlled trial.
    Jiang Y; Guo H; Liu Y; Wang X; Liang J; Xi R; Bai R; Shi D
    Trials; 2019 Apr; 20(1):218. PubMed ID: 30987658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter, 14-week study of telmisartan and ramipril in patients with mild-to-moderate hypertension using ambulatory blood pressure monitoring.
    Lacourcière Y; Neutel JM; Davidai G; Koval S
    Am J Hypertens; 2006 Jan; 19(1):104-12. PubMed ID: 16461201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y; Neutel JM; Schumacher H
    Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of Chinese Herbal Medicine Compared With Losartan for Mild Essential Hypertension: A Randomized, Multicenter, Double-Blind, Noninferiority Trial.
    Lai X; Dong Z; Wu S; Zhou X; Zhang G; Xiong S; Wu W; Cao R; Wang X; Hua Q; Du J; Fan J; Mao J; Jiang W; Yuan H; Chen Y; Xu Y; Li Z; Zhang J; Dong G; Zhen H; Ding R; Wu Z; Gao Y
    Circ Cardiovasc Qual Outcomes; 2022 Mar; 15(3):e007923. PubMed ID: 35105177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The regulatory mechanism of songling xuemaikang capsule on PPARgamma in spontaneously hypertensive rats: an experimental study].
    Zhao YQ; Liu W; Cai XY; Xu Q; Shi H; Wang W; Wu CY; Li J; Wang RH; Jiang HT
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Sep; 33(9):1236-41. PubMed ID: 24273981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of ambulatory blood pressure monitoring to evaluate the selective angiotensin II receptor antagonist, telmisartan, and other antihypertensive drugs.
    Neutel JM
    Blood Press Monit; 2000; 5 Suppl 1():S35-40. PubMed ID: 10904241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Songling Xuemaikang Capsule inhibits isoproterenol-induced cardiac hypertrophy via CaMKIIδ and ERK1/2 pathways.
    Qi J; Tan Y; Fan D; Pan W; Yu J; Xu W; Wu J; Zhang M
    J Ethnopharmacol; 2020 May; 253():112660. PubMed ID: 32061912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicentre, 12-week study of imidapril and candesartan cilexetil in patients with mild to moderate hypertension using ambulatory blood pressure monitoring.
    Palma-Gamiz JL; Pêgo M; Marquez E; Pujol M; Olivan J; Alegría E; Sagastagoitia-Gorostiza JD; Gonzalez-Juanatey JR
    Clin Drug Investig; 2007; 27(6):407-17. PubMed ID: 17506591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Systematic evaluation of efficacy and safety of Songling Xuemaikang Capsules in treatment of essential hypertension].
    Fan GH; Xing ZY; Liu ML; Chen Y; An YP; Chen ZQ; Wang YX
    Zhongguo Zhong Yao Za Zhi; 2021 Jan; 46(2):467-477. PubMed ID: 33645136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective, randomized, open-label trial comparing telmisartan 80 mg with valsartan 80 mg in patients with mild to moderate hypertension using ambulatory blood pressure monitoring.
    Littlejohn T; Mroczek W; Marbury T; VanderMaelen CP; Dubiel RF
    Can J Cardiol; 2000 Sep; 16(9):1123-32. PubMed ID: 11021956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Switching patients with uncontrolled hypertension on amlodipine 10 mg to single-pill combinations of telmisartan and amlodipine: results of the TEAMSTA-10 study.
    Neldam S; Edwards C; Jones R;
    Curr Med Res Opin; 2011 Nov; 27(11):2145-53. PubMed ID: 21955225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
    Shimada K; Ogihara T; Saruta T; Kuramoto K;
    Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period.
    White WB; Lacourciere Y; Davidai G
    Am J Hypertens; 2004 Apr; 17(4):347-53. PubMed ID: 15062889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A propensity score matched comparison of blood pressure lowering in essential hypertension patients treated with antihypertensive Chinese herbal Medicine: comparing the real-world registry data vs. randomized controlled trial.
    Lai X; Fang Z; Dong Z; Wu S; Zhou X; Gao Y
    Clin Exp Hypertens; 2023 Dec; 45(1):2249269. PubMed ID: 37639695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telmisartan plus amlodipine in patients with moderate or severe hypertension: results from a subgroup analysis of a randomized, placebo-controlled, parallel-group, 4 x 4 factorial study.
    Littlejohn TW; Majul CR; Olvera R; Seeber M; Kobe M; Guthrie R; Oigman W;
    Postgrad Med; 2009 Mar; 121(2):5-14. PubMed ID: 19332958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Traditional Chinese versus integrative treatment in elderly patients with isolated systolic hypertension: a multicenter, randomized, double-blind controlled trial.
    Li H; Liu LT; Zhao WM; Liu JG; Yao MJ; Han YX; Shen YP; Liu XD; Liu L; Wang XM; Cai LL; Guan J
    Zhong Xi Yi Jie He Xue Bao; 2010 May; 8(5):410-6. PubMed ID: 20456838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.